| Subject: | Qualitest Pharmaceuticals Issues Nationwide Voluntary Recall of AccuSure Insulin Syringes |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Fri, 17 Jun 2005 - 10:00 am |
| Qualitest Pharmaceuticals, Inc. issued a voluntary nationwide recall of AccuSure Insulin Syringes 1cc, 28 gauge 1/2 inch, that were distributed between October 2004 and June 2005. This product was distributed to drug wholesalers, distributors and pharmacies within the United States.
The 1cc syringes may be mislabeled as 1/2cc syringes on the plastic inner wrap holding 10 individual syringes. This could potentially result in confusion to the patient or caregiver that could result in an... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
Related MCN Products:
|
|
With over 20 years experience in regulatory compliance, MCN Healthcare brings you the most comprehensive regulatory compliance tool available. StayAlert! is the only comprehensive e-mail notification service available that not only notifies you of the changes in major federal regulations, but also provides the policies, procedures, tools and best practices to help you meet the changing regulation. StayAlert! actively monitors TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others so you don't have to. The strength of StayAlert! rests in its ability to allow healthcare organizations to streamline their businesses using the Internet as a foundation architecture. StayAlert! provides cost containment and reduction through elimination of unnecessary overhead, and work caused by errors or poor access to information. |
|
